SBSB
BHC icon

Sullivan, Bruyette, Speros & Blaney’s Bausch Health BHC Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$555K Buy
17,500
+1,000
+6% +$29.3K 0.02% 171
2020
Q4 		$343K Hold
16,500
– – 0.02% 205
2020
Q3 		$256K Buy
+16,500
New +$284K 0.01% 222

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's BHC Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney increased its Bausch Health (BHC) stake by 6.1% in Q1 2021, buying an estimated $29.3K and bringing the position to 17,500 shares worth $555K. The position accounts for 0.02% of the portfolio, ranked #171.

Sullivan, Bruyette, Speros & Blaney first reported a position in BHC in Q3 2020 and has held it in 3 quarters since. 352 funds tracked by Wall St. Rank hold BHC as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 17,500 shares of Bausch Health worth $555K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney bought 1,000 Bausch Health shares in Q1 2021, an estimated $29.3K.
  • Bausch Health made up 0.02% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #171 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Bausch Health in Q3 2020 and has held it in 3 quarters since.
  • 352 funds tracked by Wall St. Rank held Bausch Health as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.